{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:57:54Z","timestamp":1761541074207},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T00:00:00Z","timestamp":1332892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0032894","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T21:14:39Z","timestamp":1332969279000},"page":"e32894","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Statins but Not Aspirin Reduce Thrombotic Risk Assessed by Thrombin Generation in Diabetic Patients without Cardiovascular Events: The RATIONAL Trial"],"prefix":"10.1371","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct00793754","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Alejandro","family":"Macchia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00e1s","family":"Laffaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo D.","family":"Comignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Cornejo Pucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Igarzabal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra S.","family":"Scazziota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier A.","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio C.","family":"Bragagnolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianni","family":"Tognoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Nicolucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,3,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1056\/NEJM200004063421408","article-title":"Coronary heart disease in patients with diabetes.","volume":"342","author":"SM Haffner","year":"2000","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.","volume":"339","author":"SM Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/diacare.28.suppl_1.S4","article-title":"Standards of Medical Care in Diabetes.","volume":"28","year":"2005","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"b4531","DOI":"10.1136\/bmj.b4531","article-title":"Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.","volume":"339","author":"G De Berardis","year":"2009","journal-title":"BMJ"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.diabres.2009.09.029","article-title":"Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.","volume":"87","author":"C Zhang","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"a1840","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.","volume":"337","author":"J Belch","year":"2008","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1001\/jama.2008.623","article-title":"Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.","volume":"300","author":"H Ogawa","year":"2008","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.numecd.2004.04.001","article-title":"Use of antiplatelet therapy in a diabetic outpatient service of a large urban public hospital.","volume":"15","author":"A Bruno","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/bmj.38793.468449.AE","article-title":"Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials.","volume":"332","author":"J Costa","year":"2006","journal-title":"BMJ"},{"key":"ref11","first-page":"117","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.","volume":"2008;371","year":"2008","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.2337\/dc11-s210","article-title":"Antiplatelet therapy for every diabetic person?.","volume":"34","author":"A Nicolucci","year":"2011","journal-title":"Diabetes Care"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jama.296.4.397","article-title":"Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation.","volume":"296","author":"G Hron","year":"2006","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(06)68263-9","article-title":"Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls.","volume":"367","author":"Z Ye","year":"2006","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1160\/TH06-07-0408","article-title":"Thrombin generation, a function test of the haemostatic-thrombotic system.","volume":"96","author":"HC Hemker","year":"2006","journal-title":"Thromb Haemost"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5414\/CPP40135","article-title":"Effects of antiplatelet agents on platelet-induced thrombin generation.","volume":"40","author":"W Wegert","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and Classification of Diabetes Mellitus.","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-9560-4-5","article-title":"Thrombin generation by activated factor VII on platelet activated by different agonists. Extending the cell-based model of hemostasis.","volume":"4","author":"R Altman","year":"2006","journal-title":"Thromb J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma.","volume":"33","author":"HC Hemker","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1745-6215-8-21","article-title":"Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins.","volume":"8","author":"G De Berardis","year":"2007","journal-title":"Trials"},{"key":"ref21","article-title":"Current Controlled Trials website."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1160\/TH04-07-0453","article-title":"Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirin.","volume":"93","author":"V Evangelista","year":"2005","journal-title":"Thromb Haemost"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1161\/01.CIR.0000015422.86569.52","article-title":"Why are some individuals resistant to the cardioprotective effects of aspirin?","volume":"105","author":"MK Halushka","year":"2002","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.2337\/diacare.24.8.1476","article-title":"Platelet dysfunction in type 2 diabetes.","volume":"24","author":"AI Vinik","year":"2001","journal-title":"Diabetes Care"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0167-5273(02)00195-X","article-title":"Beyond lipid lowering: the role of statins in vascular protection.","volume":"86","author":"JK Liao","year":"2002","journal-title":"Int J Cardiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1210\/jcem.87.4.8412","article-title":"Pleiotropic effects of statins: lipid reduction and beyond.","volume":"87","author":"SI McFarlane","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/01.CIR.103.18.2248","article-title":"Simvastatin Depresses Blood Clotting by Inhibiting Activation of Prothrombin, Factor V, and Factor XIII and by Enhancing Factor Va Inactivation.","volume":"103","author":"A Undas","year":"2001","journal-title":"Circulation"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/01.ATV.0000168913.25278.38","article-title":"Simvastatin given for 3 days can inhibit thrombin generation and activation of factor V and enhance factor Va inactivation in hypercholesterolemic patients.","volume":"25","author":"A Undas","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(08)60768-0","article-title":"Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies.","volume":"371","author":"T Mazzone","year":"2008","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMra1011670","article-title":"The hemostatic system as a modulator of atherosclerosis.","volume":"364","author":"JI Borissoff","year":"2011","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00392-010-0179-x","article-title":"Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions.","volume":"99","author":"T Geisler","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/ATVBAHA.111.223453","article-title":"Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly: the Three-City cohort study.","volume":"31","author":"L Carcaillon","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0032894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T05:53:17Z","timestamp":1561528397000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0032894"}},"subtitle":[],"editor":[{"given":"Giorgio","family":"Sesti","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,28]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0032894","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,28]]}}}